Overall, while the possibility of monoallelic CNVs in PRKN conferring a higher risk of SCZ or ASD remains, as low‐penetrance from monoallelic CNVs in PRKN for Parkinson's disease (PD) has been suggested,30 our data showed that any potential risk should be limited. This evidence concerns the gene PRKN and Parkinson disease.